FDG PET/CT in the management of colorectal and anal cancers.
CT remains the imaging modality of choice in the diagnosis of colorectal cancer (CRC) and anal cancer. However, advances in imaging have expanded the role of MRI and PET/CT. This article focuses on the evolving role of FDG PET/CT in the diagnosis, radiation therapy planning, therapy assessment, and posttherapy monitoring of CRC and anal cancer. FDG PET/CT is a valuable imaging modality that impacts the clinical management of patients with CRC and those with anal cancer.